CLINICAL_TRIALS
research
· 2025-08-01
Clinical Trial Update: A Study of CT0596 in Plasma Cell Leukemia [EARLY_Phase 1]
Summary
An early-phase 1 clinical trial evaluating CT0596 for plasma cell leukemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Plasma Cell Leukemia | EARLY_Phase 1 | Status: RECRUITING